{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T03:12:48Z","timestamp":1792897968882,"version":"4.5.0"},"reference-count":26,"publisher":"European Respiratory Society (ERS)","issue":"155","license":[{"start":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T00:00:00Z","timestamp":1584662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2020,2,17]]},"published-print":{"date-parts":[[2020,3,31]]},"abstract":"<jats:p>A variety of phenotypic categorisations have been developed for sarcoidosis. Phenotyping has been used for genetics studies and to guide treatment selection. The authors participated in a Delphi expert consensus panel to develop a proposed phenotype categorisation and treatment recommendations for pulmonary sarcoidosis patients. Panellists reached consensus that asymptomatic patients with normal pulmonary function and adenopathy alone or normal chest imaging do not require therapy, while symptomatic patients with impaired pulmonary function or infiltrates should be treated. The panel did not reach consensus on asymptomatic patients with abnormal chest imaging or reduced pulmonary function, or symptomatic patients with normal chest imaging and pulmonary function. The proposed phenotype categories and associated treatment recommendations are asymptomatic (no therapy), acute (disease duration &lt;1\u20132\u2005years, apparently self-limited, corticosteroids), chronic (antimetabolites and other second-line therapies) and advanced (biologics). Some clinical settings, such as dyspnoea\/hypoxaemia at rest, severely impaired or rapidly decreasing pulmonary function tests, and severe cardiac, neurologic, ocular or renal involvement warrant immediate therapy.<\/jats:p>","DOI":"10.1183\/16000617.0145-2019","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T16:05:50Z","timestamp":1584720350000},"page":"190145","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":41,"title":["Clinical phenotyping: role in treatment decisions in sarcoidosis"],"prefix":"10.1183","volume":"29","author":[{"given":"Robert P.","family":"Baughman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Beth","family":"Scholand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck F.","family":"Rahaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,3,20]]},"reference":[{"key":"2024102403441044000_29.155.190145.1","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102403441044000_29.155.190145.2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MCP.0000000000000077","article-title":"Clinical phenotypes in sarcoidosis","volume":"20","author":"Pereira","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"2024102403441044000_29.155.190145.3","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-11-25"},{"key":"2024102403441044000_29.155.190145.4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1055\/s-0028-1112616","article-title":"The significance of stage classification of sarcoidosis (Boeck's disease)","volume":"85","author":"Wurm","year":"1960","journal-title":"Dtsch Med Wochenschr"},{"key":"2024102403441044000_29.155.190145.5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5261.1165"},{"key":"2024102403441044000_29.155.190145.6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200608-1197OC"},{"key":"2024102403441044000_29.155.190145.7","first-page":"525","article-title":"Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients","volume":"52","author":"Neville","year":"1983","journal-title":"Q J Med"},{"key":"2024102403441044000_29.155.190145.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200807-1082OC"},{"key":"2024102403441044000_29.155.190145.9","doi-asserted-by":"publisher","DOI":"10.1378\/chest.129.5.1234"},{"key":"2024102403441044000_29.155.190145.10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200705-742OC"},{"key":"2024102403441044000_29.155.190145.11","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102403441044000_29.155.190145.12","first-page":"34","article-title":"Factor analysis of sarcoidosis phenotypes at two referral centers in Brazil","volume":"28","author":"Rodrigues","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102403441044000_29.155.190145.13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"2024102403441044000_29.155.190145.14","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201503-172OT"},{"key":"2024102403441044000_29.155.190145.15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00991-2017"},{"key":"2024102403441044000_29.155.190145.16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1055\/s-0035-1547318","article-title":"Genotypes and phenotypes in cystic fibrosis and cystic fibrosis transmembrane regulator-related disorders","volume":"36","author":"Bombieri","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"issue":"Suppl. 6","key":"2024102403441044000_29.155.190145.17","first-page":"70S","article-title":"Finding disease genes. From cystic fibrosis to sarcoidosis. Thomas A. Neff Lecture","volume":"111","author":"Iannuzzi","year":"1997","journal-title":"Chest"},{"key":"2024102403441044000_29.155.190145.18","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.4782"},{"key":"2024102403441044000_29.155.190145.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2007.00904.x"},{"key":"2024102403441044000_29.155.190145.20","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440370104011"},{"key":"2024102403441044000_29.155.190145.21","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0146-2019"},{"key":"2024102403441044000_29.155.190145.22","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.rmed.2015.01.019","article-title":"The effect of corticosteroids on quality of life in a sarcoidosis clinic: the results of a propensity analysis","volume":"109","author":"Judson","year":"2015","journal-title":"Respir Med"},{"key":"2024102403441044000_29.155.190145.23","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcl038"},{"key":"2024102403441044000_29.155.190145.24","doi-asserted-by":"publisher","DOI":"10.1378\/chest.111.3.623"},{"key":"2024102403441044000_29.155.190145.25","first-page":"275","article-title":"Features of sarcoidosis associated with chronic disease","volume":"31","author":"Baughman","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2024102403441044000_29.155.190145.26","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0147-2019"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0145-2019","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T05:01:30Z","timestamp":1740373290000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0145-2019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,20]]},"references-count":26,"journal-issue":{"issue":"155","published-online":{"date-parts":[[2020,3,20]]},"published-print":{"date-parts":[[2020,3,31]]}},"alternative-id":["10.1183\/16000617.0145-2019"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0145-2019","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,20]]}}}